Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
143 |
|
| Actual shortage: | 17 (12%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 125 (87%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (20%) |
|
Overdue reports |
4 (24%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-02-03 | 35498 |
| MINT-PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-17 | 35501 |
| MINT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46030 |
| MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
| MINT-QUETIAPINE | 200MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46038 |
| MINT-QUETIAPINE | 300MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46041 |
| MINT-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-04-11 | 217384 |
| MINT-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-10-31 | 217387 |
| MINT-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217390 |
| MINT-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217393 |
| MINT-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-04-11 | 217396 |
| MINT-RAMIPRIL | 15.0MG | CAPSULE | Resolved | 2020-08-19 | 2021-01-11 | 122510 |
| MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
| MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-08-22 | 2024-12-05 | 92272 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Actual shortage | 2025-03-18 | 2025-07-31 | 252950 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Actual shortage | 2025-03-18 | 2025-07-31 | 252953 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-08-22 | 2024-12-05 | 92275 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |